Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ArterX is a surgical sealant medical device developed by Tenaxis Medical for use in vascular reconstruction procedures. It consists of a two-part liquid system that, when mixed and applied, transforms into a flexible gel in less than 15 seconds. The sealant achieves hemostasis by mechanically sealing areas of leakage, such as suture lines, through a proprietary technology involving a crosslinking agent that covalently binds to proteins in both the sealant and the surrounding human tissue. It is indicated for prophylactic use and for treating bleeding after clamp release in procedures like carotid endarterectomy, lower extremity bypass, and arteriovenous (AV) grafts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ArterX.